The AI infrastructure boom is in full swing! Liquid cooling leader Vertiv (VRT.US) has soared 127% this year, and Wall Street analysts can barely keep up.
Vertiv's stock price has been on a strong and rapid rise, with a year-to-date increase of up to 127%. The rapid increase has even surpassed the valuation predictions of many Wall Street analysts.
Citigroup has raised the price target for Vertiv Holdings (VRT.US) from $353 to $414, maintaining a "buy" rating. The new target price is 13% higher than the current stock price. It is worth mentioning that with the boost of the current AI infrastructure market, Vertiv's stock price has been surging, with a year-to-date increase of 127%. The rapid rise in stock price has even outpaced the valuation predictions of many Wall Street analysts.
Citigroup emphasized that Vertiv's future sales and profit growth prospects are clear for the next several years, mainly due to its large-scale investments in AI data centers. In addition, Citigroup expects Vertiv to raise its long-term organic growth expectations to 12%-24%.
Vertiv's first-quarter financial report released last month showed a 30% year-on-year increase in net sales to $2.65 billion, with adjusted earnings per share increasing by 83% to $1.17, both surpassing market expectations. In addition, the company saw a 23% increase in organic sales in the first quarter. This was also Vertiv's first quarterly report after being included in the S&P 500 index in March.
Vertiv CEO Giordano Albertazzi stated in the financial report that the company's strong financial performance reflects its ability to meet customer demands.
He added, "We see significant changes in data center infrastructure needs, with customers prioritizing optimized design, deployment speed, and operational efficiency, reshaping their deployment methods. This quarter's financial performance reflects our unique ability to meet customer needs at this critical moment. Our investments in technology and capacity, as well as strategic acquisitions, are translating into market share growth as customers require faster deployment speeds, higher reliability, and more comprehensive services. With increased infrastructure density and shortened deployment cycles, we are ready to be a partner for customers to achieve their grandest projects and achieve scalable deployments."
Vertiv is rising too fast, and Wall Street analysts are struggling to keep up.
Data compiled by Tipranks shows that out of 17 analysts covering Vertiv, 15 have a "buy" rating, 2 have a "hold" rating, with a consensus rating of "strong buy" and an average target price of $347.50, which is 5% lower than the current stock price.
It is worth noting that Vertiv's stock price continues to soar, with a 127% increase year-to-date.
Vertiv is widely regarded as a leading company in the global liquid cooling and AI data center infrastructure field, especially in liquid cooling, power management, and high-density computing support. The company is also a data center cooling technology partner of the AI giant NVIDIA Corporation (NVDA.US).
With the increasing power consumption of new generation chips, liquid cooling machines are becoming increasingly popular among data center operators. Vertiv plans to release an 800 VDC power product portfolio in the second half of 2026 to complement NVIDIA Corporation's Rubin Ultra platform set to launch in 2027.
In addition to its expertise in liquid cooling products, Vertiv also provides uninterruptible power supply (UPS) systems and server racks for data centers, as well as services for communication network applications.
Related Articles

MICROPORT NEURO (02172) spent 986,500 Hong Kong dollars to repurchase 100,000 shares on May 13th.

7ROAD (00797) repurchased 20,000 shares for HK$11,400 on May 13th.

On May 13th, DINGDANG HEALTH (09886) spent 2.9257 million Hong Kong dollars to repurchase 2.887 million shares.
MICROPORT NEURO (02172) spent 986,500 Hong Kong dollars to repurchase 100,000 shares on May 13th.

7ROAD (00797) repurchased 20,000 shares for HK$11,400 on May 13th.

On May 13th, DINGDANG HEALTH (09886) spent 2.9257 million Hong Kong dollars to repurchase 2.887 million shares.

RECOMMEND

Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026

HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026

The Chip Stock Frenzy Is Still Accelerating
11/05/2026


